Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients With Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation Therapy

被引:22
作者
Ghiassi-Nejad, Zahra [1 ]
Tarchi, Paola [4 ]
Moshier, Erin [2 ]
Ru, Meng [2 ]
Tabrizian, Parissa [3 ]
Schwartz, Myron [3 ]
Buckstein, Michael [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, 1184 5th Ave,First Floor, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA
[4] Dept Gen Surg, Trieste, Italy
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 04期
关键词
INTRAHEPATIC CHOLANGIOCARCINOMA; IMPROVED SURVIVAL; GASTRIC-CANCER; RECURRENCE; RADIOTHERAPY; PATHOGENESIS; GEMCITABINE; MANAGEMENT;
D O I
10.1016/j.ijrobp.2017.06.2467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To identify prognostic factors and patterns of local failure in patients with cholangiocarcinoma (CCA), after surgical resection in the absence of adjuvant radiation, for optimal definition of target volumes encompassing the majority of local recurrences. Methods and Materials: A chart review was performed in patients who underwent resection for primary CCA (intrahepatic, hilar, and distal) between 1999 and 2014. Local failure was defined as recurrence in a theoretical reasonable postoperative radiation volume. This includes the cut surface of liver, biliary anastomosis, hilum, portal nodes, celiac nodes, peri-pancreatic nodes, gastro-hepatic nodes, and retroperitoneal nodes. Patients who received adjuvant radiation were excluded. Results: A total of 189 patients underwent surgical resection for CCA, of whom 145 patients had sufficient follow-up. Median follow-up was 41.6 months (95% confidence interval 35.4-48.7 months). Of the 145 cases, 102 were intrahepatic and 43 were hilar/distal CCA. Adjuvant chemotherapy was given in 38 cases (26%), of which 20 (54%) were gemcitabine-based. Eighty-six patients (59%) had a documented recurrence, of whom 44 (51%) had a locoregional component. Among patients who had a recurrence, 23 (27%) had a recurrence at the biliary anastomosis and/or cut liver surface. Twenty-eight patients (32.6%) had a recurrence in the regional lymph nodes, most prevalent in the portal (16.3%) and retroperitoneal (17.4%) lymph nodes. Univariable analysis identified tumor size, any vascular invasion, presence of satellites, stage/nodal status, and receipt of chemotherapy as significant prognostic factors of overall recurrence among intrahepatic patients. Presence of satellites, and stage 3/Nx status remained statistically significant in multivariable modeling. Conclusions: The areas at highest risk for locoregional recurrence after surgical resection for primary CCA are the biliary anastomosis/cut liver surface, portal lymph nodes, and retroperitoneal lymph nodes. Although these results need to be validated, adjuvant radiation should possibly cover these areas to maximize locoregional control. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 16 条
  • [1] SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
    Ben-Josef, Edgar
    Guthrie, Katherine A.
    El-Khoueiry, Anthony B.
    Corless, Christopher L.
    Zalupski, Mark M.
    Lowy, Andrew M.
    Thomas, Charles R., Jr.
    Alberts, Steven R.
    Dawson, Laura A.
    Micetich, Kenneth C.
    Thomas, Melanie B.
    Siegel, Abby B.
    Blanke, Charles D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2617 - U57
  • [2] Mapping Patterns of Local Recurrence After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A New Approach to Adjuvant Radiation Field Design
    Dholakia, Avani S.
    Kumar, Rachit
    Raman, Siva P.
    Moore, Joseph A.
    Ellsworth, Susannah
    McNutt, Todd
    Laheru, Daniel A.
    Jaffee, Elizabeth
    Cameron, John L.
    Tran, Phuoc T.
    Hobbs, Robert F.
    Wolfgang, Christopher L.
    Herman, Joseph M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 1007 - 1015
  • [3] Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection
    Endo, Itaru
    Gonen, Mithat
    Yopp, Adam C.
    Dalal, Kimberly M.
    Zhou, Qin
    Klimstra, David
    DAngelica, Michael
    DeMatteo, Ronald P.
    Fong, Yuman
    Schwartz, Lawrence
    Kemeny, Nancy
    O'Reilly, Eileen
    Abou-Alfa, Ghassan K.
    Shimada, Hiroshi
    Blumgart, Leslie H.
    Jarnagin, William R.
    [J]. ANNALS OF SURGERY, 2008, 248 (01) : 84 - 96
  • [4] Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study
    Gil, Eunmi
    Joh, Jae-Won
    Park, Hee Chul
    Yu, Jeong Il
    Jung, Sang Hoon
    Kim, Jong Man
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [5] Gastric cancer-patterns of relapse after surgical resection
    Gunderson, LL
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (02) : 150 - 161
  • [6] Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Horgan, Anne M.
    Amir, Eitan
    Walter, Thomas
    Knox, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1934 - 1940
  • [7] Recurrence after operative management of intrahepatic cholangiocarcinoma
    Hyder, Omar
    Hatzaras, Ioannis
    Sotiropoulos, Georgios C.
    Paul, Andreas
    Alexandrescu, Sorin
    Marques, Hugo
    Pulitano, Carlo
    Barroso, Eduardo
    Clary, Bryan M.
    Aldrighetti, Luca
    Ferrone, Cristina R.
    Zhu, Andrew X.
    Bauer, Todd W.
    Walters, Dustin M.
    Groeschl, Ryan
    Gamblin, T. Clark
    Marsh, J. Wallis
    Nguyen, Kevin T.
    Turley, Ryan
    Popescu, Irinel
    Hubert, Catherine
    Meyer, Stephanie
    Choti, Michael A.
    Gigot, Jean-Francois
    Mentha, Gilles
    Pawlik, Timothy M.
    [J]. SURGERY, 2013, 153 (06) : 811 - 818
  • [8] Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
    Ilyas, Sumera I.
    Gores, Gregory J.
    [J]. GASTROENTEROLOGY, 2013, 145 (06) : 1215 - 1229
  • [9] Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
    Khan, S. A.
    Toledano, M. B.
    Taylor-Robinson, S. D.
    [J]. HPB, 2008, 10 (02) : 77 - 82
  • [10] Cholangiocarcinoma - A spectrum of intrahepatic, perihilar, and distal tumors
    Nakeeb, A
    Pitt, HA
    Sohn, TA
    Coleman, J
    Abrams, RA
    Piantadosi, S
    Hruban, RH
    Lillemoe, KD
    Yeo, CJ
    Cameron, JL
    [J]. ANNALS OF SURGERY, 1996, 224 (04) : 463 - 473